Drug-drug Interaction Study with GLPG4716 and Nintedanib and Pirfenidone in Healthy Subjects
Clinical trial NCT04971746 · COMPLETED
Trial details
- NCT number
- NCT04971746
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-19
- Primary completion
- 2022-05-09
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.